Skip to main content
// //

Aphria Inc.

Register
AdChoices

Aphria Inc.

Latest
advisor stocks
Is cannabis still a long-term play worth considering?
Globe Advisor content
report on business
Aphria suspends outlook, reports $144.4-million in revenue amid COVID-19
inside the market
What every Canadian investor needs to know today
Subscriber content
report on business
Aphria investment raises $100-million from unnamed institutional investor
cannabis
Aphria signs $100-million deal with unidentified institutional investor
Subscriber content
report on business
Aphria cuts outlook for 2020, reports second-quarter loss
Subscriber content

More Stories Below Advertisement

cannabis
Aphria cuts 2020 outlook as cannabis company faces setbacks in Ontario, Alberta
Subscriber content
inside the market
Pot-stock interest fizzled in 2019. These charts show how much
board games 2019
How we ranked Canada’s corporate boards
Subscriber content
cannabis
Canadian regulators warn cannabis companies to improve conflict-of-interest disclosures
Subscriber content
cannabis
All dried up: How Bay Street cashed in on the cannabis frenzy before the carnage
Subscriber content
report on business
Aphria gives new CEO $10-million pay package
Subscriber content
report on business cannabis professional
Aleafia cancels supply agreement with Aphria, cites ‘consistent failure’ to meet obligations
Subscriber content
number cruncher
Four cannabis stocks for the longer-term investor as the market hype cools
Subscriber content
inside the market
Market movers: Stocks that saw action on Friday - and why
Subscriber content
cannabis
Aphria president Jakob Ripshtein resigning as company names new executives
Subscriber content

More Stories Below Advertisement

stars and dogs
The Globe’s stars and dogs for the week
cannabis
Investors punish Aphria as quarterly pot sales disappoint in wake of legalization
Subscriber content
cannabis
Aphria shares drop on $108-million loss, including impairment charge on Latin American assets
Subscriber content
cannabis
Aurora and Aphria selected to grow medical cannabis in Germany
Subscriber content
inside the market
Market movers: Stocks that saw action on Monday - and why
Subscriber content
report on business
How two Canadian financiers took an obscure Apple reseller for a wild ride
Subscriber content
streetwise newsletter
Streetwise newsletter: Best reads of the week
Subscriber content
cannabis
Aphria says review reveals conflict of interest of some directors in Latin American acquisition
Subscriber content
cannabis
Aphria reveals some directors in Latin American acquisition had ‘conflicts’
Subscriber content
streetwise
Aphria’s former legal adviser brokered first meeting with hostile bidder
Subscriber content
cannabis
Cannabis grower Aphria rejects takeover bid by Green Growth
Subscriber content
cannabis
Aphria rejects takeover bid by Green Growth
Subscriber content
inside the market
Market movers: Key stocks seeing action Monday - and why
Subscriber content
cannabis
Green Growth’s Aphria play: Why the hostile takeover bid is so unusual – and so bold
Subscriber content
inside the market
Short sales on the TSX: What bearish investors are betting against
Subscriber content
cannabis
Aphria urges patience while committee reviews Green Growth hostile bid
Subscriber content
cannabis
Green Growth Brands formally files offer to buy Aphria
Subscriber content
streetwise newsletter
Streetwise newsletter: Best reads of the week
Subscriber content
cannabis
Aphria confirms CEO, co-founder to exit embattled cannabis producer
Subscriber content
cannabis
Aphria CEO to step down amid questions about cannabis firm’s deal-making, slumping stock
Subscriber content
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies